Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Ductal Carcinoma of Female Breast”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Early research (Phase 1)Study completedNCT00290732
What this trial is testing

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Not applicableLooking for participantsNCT04985032
What this trial is testing

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

Who this might be right for
Ductal Carcinoma in SituInvasive Ductal Carcinoma of Female Breast
RPCR, Inc. 200
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableUnknownNCT00602316
What this trial is testing

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00058058
What this trial is testing

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Who this might be right for
Breast CancerContralateral Breast Cancer
American College of Radiology Imaging Network 1,007
Not applicableUnknownNCT02909426
What this trial is testing

The Mammography and Ultrasonography STudy for Breast Cancer Screening Effectiveness

Who this might be right for
Invasive CancerDuctal Carcinoma in Situ
Soonchunhyang University Hospital 11,880
Testing effectiveness (Phase 2)Study completedNCT03113825
What this trial is testing

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Who this might be right for
Primary Invasive Malignant Neoplasm of Female BreastCarcinoma BreastBreast Cancer Female+4 more
Avelas Biosciences, Inc. 92
Large-scale testing (Phase 3)Study completedNCT02125344
What this trial is testing

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Who this might be right for
Tubular Breast Cancer Stage IITubular Breast Cancer Stage IIIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 961
Large-scale testing (Phase 3)Study completedNCT01426880
What this trial is testing

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 595
Not applicableUnknownNCT00536718
What this trial is testing

Genetics of Women With Lobular Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
National Cancer Research Network 3,000
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Not applicableStudy completedNCT00182728
What this trial is testing

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 89
Large-scale testing (Phase 3)Study completedNCT00002967
What this trial is testing

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc
Testing effectiveness (Phase 2)Study completedNCT00960336
What this trial is testing

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
ARCAGY/ GINECO GROUP 59
Load More Results